Welcome to Long lab!

We are in the Institute of Basic Medical Sciences (IBMS) at Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical College (PUMC), the leading Medical School in China. 

News

05/04/2023. Peixing's perspective is published in Cell Genomics. Congrats!

05/08/2023. Long lab officially launched.

05/12/2023. Erping received the NSFC Excellent Youth Scholar Fund of ~$500,000 for 3-year support. Congrats!

06/07/2023. Erping received the CAMS Innovation Fund (2023-I2M-3-010) of ~$1,000,000 for 5-year support. Congrats!

08/25/2023. Yuyan won the Reviewers' Choice Award (10% top scored poster) in the ASHG 2023!! Congrats Yuyan!!

08/26/2023. Erping received the NSFC Youth Fund of ~$50,000 for 3-year support. Congrats!

10/13/2023. Junling received the China Health & Longevity Award of ~$60,000 for 2-year support. Congrats!

10/30/2023. Our study of antagonistic pleiotropy is accepted in Science Advances. Congrats!

12/09/2023. Our study of antagonistic pleiotropy is highlighted by The New York Times. Congrats!

05/05/2024. Our study of lung cancer MPRA is accepted in American Journal of Human Genetics. Congrats!

05/15/2024. Xiaolin's study of sex difference in exceptional longevity is published in Diabetes & Metabolic Syndrome: Clinical Research & Reviews. Congrats!

06/06/2024. The large language model SSPEC study (involving Peixing, Zigeng, and Wenjun) is accepted in Nature Medicine. Congrats!

08/02/2024. The human lung multiomics study (involving Yuyan, Xinti, and Cong) is accepted in Nature Communications. Congrats!

08/31/2024. Erping received the NSFC R01 Fund of ~$80,000 for 4-year support. Congrats!

09/18/2024. Our study of large language model SSPEC is featured by Nature Medicine. Congrats!

09/22/2024. Zigeng won the Young Scholar Award in BME China 2024!! Congrats!

12/12/2024. Our team received the NSFC AI Medicine Fund of ~$250,000 for 3-year support. Congrats!

12/19/2024. Xinti, Wenjun, and Zigeng's commentary is accepted in Clinical and Translational Medicine. Congrats!

01/09/2025. Our perspective of multiple causal variants is accepted in American Journal of Human Genetics. Congrats!

02/16/2025. Our team (lead role) received the National Key R&D Program of ~$1,200,000 for 4-year support. Congrats!

03/29/2025. Our study of large language model SSPEC is recognized as Top 10 Notable Advances of AI Medicine 2025 in China. Congrats!

06/17/2025. Xiaolin was promoted to Associate Investigator! Congrats! Prof. Ni! 

08/04/2025. Xiaolin and Tingwei's perspective of immune aging is accepted in Life Medicine. Congrats!

08/08/2025. Wenqian's study of single-cell heart failure is accepted in principle in Communications Biology. Congrats!

08/19/2025. Our team received the RayWu Angel Grant of ~$40,000 to support the our LLM translation. Congrats! 

08/29/2025. Peixing received the NSFC Youth Fund of ~$50,000 for 3-year support. Congrats!